Even in the case that MHC-negative tumor subclones are already present at the beginning of the vaccination, a “hit hard and early” vaccination might have advantages since high magnitude immune responses may favor the influx of natural killer cells which preferentially recognize and eliminate MHC-negative tumor cells. Here, HLA-C is linked to neoplasm.